Cancer
NUS researchers uncover new role of TIP60 protein in controlling tumor formation
Scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have discovered a...
Statins show little promise for conditions other than heart disease
Medicines commonly prescribed to reduce people's risk of heart attack may have limited use for treating other diseases, research suggests....
Immunotherapy effective against hereditary melanoma
Individuals with an inherited form of skin cancer often have a poor prognosis. The type of immunotherapy that was awarded...
Targeted drugs for advanced cancer move from specialist units to community setting
Credit: © European Society for Medical Oncology Lugano-Munich, 9 October 2018 - Nearly 1 in 4 patients with advanced cancer,...
Evidence does not support statin use for conditions other than heart disease
Annals of Internal Medicine Tip Sheet Below please find summaries of new articles that will be published in the next...
DOD grant to fund potential treatment for metastatic breast cancer
Credit: Medical University of South Carolina Hollings Cancer Center A team of Medical University of South Carolina (MUSC) Hollings Cancer...
UCLA researchers discover aggressive prostate and lung cancers are driven by common mechanisms
Credit: Jung Wook Park & Owen Witte UCLA researchers have discovered a common process in the development of late-stage, small...
Translational research on recurrent metastatic neuroblastoma at Children’s Hospital Los Angeles
Neuroblastoma, a disease of immature nerve cells, is the most common solid tumor cancer occurring in children. About 700 new...
Mayo researchers ID potential new treatment for one type of triple-negative breast cancer
ROCHESTER, Minn. -- Mayo Clinic researchers have identified the drug estradiol as a potential new treatment for a subset of...
Low-dose aspirin may lower ovarian cancer risk
Boston, MA - Women who reported recent, regular use of low-dose aspirin (100 milligrams or less) had a 23% lower...
Scientists find old antibiotic may selectively kill dangerous skin cancer cells
An old antibiotic, called nifuroxazide, could selectively kill dangerous cells within melanomas, the deadliest type of skin cancer, scientists from...
Analysis reveals genomic effects of a new cancer treatment now in clinical trials
Credit: Eric Brown, PhD, Perelman School of Medicine, University of Pennsylvania PHILADELPHIA -A twist on the molecular mechanism of how...
Mass. General-led study supports aspirin’s ability to reduce liver cancer risk
The results of a study led by Massachusetts General Hospital (MGH) investigators support evidence from previous studies suggesting the regular...
Chemotherapy may lead to mitochondrial dysfunction in skeletal muscle
Rockville, Md. (October 4, 2018)--Chemotherapy drugs to treat breast cancer may promote muscle mitochondrial dysfunction, according to new research. Dysfunctional...
New clues about how our body guards against cancer
Credit: WEHI-TV Walter and Eliza Hall Institute, Australia Walter and Eliza Hall Institute researchers have uncovered a key factor protecting...
Mouse study mirrors human findings that link chemotherapy and APOE4 to cognitive issues
The research, led by Georgetown University Medical Center (GUMC) investigators and published in Neurotoxicity Research, complements findings from another GUMC-led...
First large study details cognitive outcomes among older breast cancer patients
WASHINGTON -- The first large U.S. study of cognition in older breast cancer patients found that within the first two...
Arizona bioscience community honors two of TGen’s top scientists
PHOENIX, Ariz. -- Oct. 3, 2018 -- Two top scientists from the Translational Genomics Research Institute (TGen), an affiliate of...
A novel molecule could spur new class of drugs for breast cancer
Credit: Stevens Institute of Technology Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class...
T cell bispecific antibody for the immune-mediated killing of HER2+ breast cancer cells
(Vall d'Hebron Institute of Oncology) Researchers at the Vall d'Hebron Institute of Oncology in Barcelona show that the p95HER2-T cell...